110 related articles for article (PubMed ID: 26810265)
1. Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
Bioorg Med Chem Lett; 2016 Feb; 26(4):1218-23. PubMed ID: 26810265
[TBL] [Abstract][Full Text] [Related]
2. Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
J Chem Inf Model; 2013 Apr; 53(4):809-20. PubMed ID: 23544417
[TBL] [Abstract][Full Text] [Related]
3. Identification of quinazolinyloxy biaryl urea as a new class of SUMO activating enzyme 1 inhibitors.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
Bioorg Med Chem Lett; 2013 Sep; 23(18):5145-9. PubMed ID: 23920437
[TBL] [Abstract][Full Text] [Related]
4. Diversification of SUMO-activating enzyme in Arabidopsis: implications in SUMO conjugation.
Castaño-Miquel L; Seguí J; Manrique S; Teixeira I; Carretero-Paulet L; Atencio F; Lois LM
Mol Plant; 2013 Sep; 6(5):1646-60. PubMed ID: 23482370
[TBL] [Abstract][Full Text] [Related]
5. Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening.
Kumar A; Ito A; Takemoto M; Yoshida M; Zhang KY
J Chem Inf Model; 2014 Mar; 54(3):870-80. PubMed ID: 24512059
[TBL] [Abstract][Full Text] [Related]
6. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate.
Fukuda I; Ito A; Hirai G; Nishimura S; Kawasaki H; Saitoh H; Kimura K; Sodeoka M; Yoshida M
Chem Biol; 2009 Feb; 16(2):133-40. PubMed ID: 19246003
[TBL] [Abstract][Full Text] [Related]
7. Viral control of the SUMO pathway: Gam1, a model system.
Chiocca S
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1419-21. PubMed ID: 18031235
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.
Qiao Z; Wang W; Wang L; Wen D; Zhao Y; Wang Q; Meng Q; Chen G; Wu Y; Zhou H
Bioorg Med Chem Lett; 2011 Nov; 21(21):6389-92. PubMed ID: 21930380
[TBL] [Abstract][Full Text] [Related]
9. Development of a high-throughput screening assay for inhibitors of small ubiquitin-like modifier proteases.
Yang W; Wang L; Paschen W
J Biomol Screen; 2013 Jun; 18(5):621-8. PubMed ID: 23470489
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors targeting the SUMOylation pathway: A patent review 2012‑2015 (Review).
Zhou Y; Ji C; Cao M; Guo M; Huang W; Ni W; Meng L; Yang H; Wei JF
Int J Mol Med; 2018 Jan; 41(1):3-12. PubMed ID: 29115401
[TBL] [Abstract][Full Text] [Related]
11. Identification of sumoylation inhibitors targeting a predicted pocket in Ubc9.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
J Chem Inf Model; 2014 Oct; 54(10):2784-93. PubMed ID: 25191977
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatical detection of recognition factors for ubiquitin and SUMO.
Vogt B; Hofmann K
Methods Mol Biol; 2012; 832():249-61. PubMed ID: 22350891
[TBL] [Abstract][Full Text] [Related]
13. Targeting SUMO Signaling to Wrestle Cancer.
Kroonen JS; Vertegaal ACO
Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
[TBL] [Abstract][Full Text] [Related]
14. Small molecule SUMOylation activators are novel neuroprotective agents.
Krajnak K; Dahl R
Bioorg Med Chem Lett; 2018 Feb; 28(3):405-409. PubMed ID: 29269215
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds.
Yang Y; Xia Z; Wang X; Zhao X; Sheng Z; Ye Y; He G; Zhou L; Zhu H; Xu N; Liang S
Mol Pharmacol; 2018 Aug; 94(2):885-894. PubMed ID: 29784649
[TBL] [Abstract][Full Text] [Related]
16. Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance.
Vigodner M; Weisburg JH; Shrivastava V; Marmor RA; Fathy J; Skop N
Cell Tissue Res; 2009 May; 336(2):277-86. PubMed ID: 19326147
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38α.
Getlik M; Grütter C; Simard JR; Nguyen HD; Robubi A; Aust B; van Otterlo WA; Rauh D
Eur J Med Chem; 2012 Feb; 48():1-15. PubMed ID: 22154891
[TBL] [Abstract][Full Text] [Related]
18. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
Ban R; Nishida T; Urano T
Genes Cells; 2011 Jun; 16(6):652-69. PubMed ID: 21554500
[TBL] [Abstract][Full Text] [Related]
19. SUMO proteases: redox regulation and biological consequences.
Xu Z; Chan HY; Lam WL; Lam KH; Lam LS; Ng TB; Au SW
Antioxid Redox Signal; 2009 Jun; 11(6):1453-84. PubMed ID: 19186998
[TBL] [Abstract][Full Text] [Related]
20. PHD3-SUMO conjugation represses HIF1 transcriptional activity independently of PHD3 catalytic activity.
Núñez-O'Mara A; Gerpe-Pita A; Pozo S; Carlevaris O; Urzelai B; Lopitz-Otsoa F; Rodríguez MS; Berra E
J Cell Sci; 2015 Jan; 128(1):40-9. PubMed ID: 25380826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
